Patients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review.
Pieringer, Herwig
Patients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review. [electronic resource] - Yonsei medical journal Jan 2013 - 253-7 p. digital
Publication Type: Journal Article; Review; Systematic Review
1976-2437
10.3349/ymj.2013.54.1.253 doi
Adalimumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis--surgery
Certolizumab Pegol
Etanercept
Humans
Immunoglobulin Fab Fragments--therapeutic use
Immunoglobulin G--therapeutic use
Infections
Infliximab
Perioperative Period
Polyethylene Glycols--therapeutic use
Postoperative Complications--prevention & control
Postoperative Period
Receptors, Tumor Necrosis Factor--therapeutic use
Retrospective Studies
Risk
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Patients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review. [electronic resource] - Yonsei medical journal Jan 2013 - 253-7 p. digital
Publication Type: Journal Article; Review; Systematic Review
1976-2437
10.3349/ymj.2013.54.1.253 doi
Adalimumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis--surgery
Certolizumab Pegol
Etanercept
Humans
Immunoglobulin Fab Fragments--therapeutic use
Immunoglobulin G--therapeutic use
Infections
Infliximab
Perioperative Period
Polyethylene Glycols--therapeutic use
Postoperative Complications--prevention & control
Postoperative Period
Receptors, Tumor Necrosis Factor--therapeutic use
Retrospective Studies
Risk
Tumor Necrosis Factor-alpha--antagonists & inhibitors